|
1
|
Fuglsang J and Ovesen P: Aspects of
placental growth hormone physiology. Growth Horm IGF Res. 16:67–85.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sifakis S, Akolekar R, Mantas N, Kappou D
and Nicolaides KH: Maternal serum human placental growth hormone
(hPGH) at 11 to 13 weeks of gestation in preeclampsia. Hypertens
Pregnancy. 30:74–82. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chellakooty M, Vangsgaard K, Larsen T,
Scheike T, Falck-Larsen J, Legarth J, Andersson AM, Main KM,
Skakkebaek NE and Juul A: A longitudinal study of intrauterine
growth and the placental growth hormone (GH)-insulin-like growth
factor I axis in maternal circulation: Association between
placental GH and fetal growth. J Clin Endocrinol Metab. 89:384–391.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Alsat E, Guibourdenche J, Luton D,
Frankenne F and Evain-Brion D: Human placental growth hormone. Am J
Obstet Gynecol. 177:1526–1534. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Caufriez A, Frankenne F, Englert Y,
Golstein J, Cantraine F, Hennen G and Copinschi G: Placental growth
hormone as a potential regulator of maternal IGF-I during human
pregnancy. Am J Physiol. 258:E1014–E1019. 1990.PubMed/NCBI
|
|
6
|
Caufriez A, Frankenne F, Hennen G and
Copinschi G: Regulation of maternal IGF-I by placental GH in normal
and abnormal human pregnancies. Am J Physiol. 265:E572–E577.
1993.PubMed/NCBI
|
|
7
|
Vatten LJ, Nilsen TI, Juul A, Jeansson S,
Jenum PA and Eskild A: Changes in circulating level of IGF-I and
IGF-binding protein-1 from the first to second trimester as
predictors of preeclampsia. Eur J Endocrinol. 158:101–105. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lacroix MC, Guibourdenche J, Fournier T,
Laurendeau I, Igout A, Goffin V, Pantel J, Tsatsaris V and
Evain-Brion D: Stimulation of human trophoblast invasion by
placental growth hormone. Endocrinology. 146:2434–2444. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lacroix MC, Bolifraud P, Durieux D,
Pauloin A, Vidaud M and Kann G: Placental growth hormone and
lactogen production by perifused ovine placental explants:
Regulation by growth hormone-releasing hormone and glucose. Biol
Reprod. 66:555–561. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takata K, Kasahara T, Kasahara M, Ezaki O
and Hirano H: Localization of erythrocyte/HepG2-type glucose
transporter (GLUT1) in human placental villi. Cell Tissue Res.
267:407–412. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barbour LA, Shao J, Qiao L, Pulawa LK,
Jensen DR, Bartke A, Garrity M, Draznin B and Friedman JE: Human
placental growth hormone causes severe insulin resistance in
transgenic mice. Am J Obstet Gynecol. 186:512–517. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
McIntyre HD, Serek R, Crane DI,
Veveris-Lowe T, Parry A, Johnson S, Leung KC, Ho KK, Bougoussa M,
Hennen G, et al: Placental growth hormone (GH), GH-binding protein,
and insulin-like growth factor axis in normal, growth-retarded, and
diabetic pregnancies: Correlations with fetal growth. J Clin
Endocrinol Metab. 85:1143–1150. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Frankenne F, Alsat E, Scippo ML, Igout A,
Hennen G and Evain-Brion D: Evidence for the expression of growth
hormone receptors in human placenta. Biochem Biophys Res Commun.
182:481–486. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harper ME, Barrera-Saldaña HA and Saunders
GF: Chromosomal localization of the human placental lactogen-growth
hormone gene cluster to 17q22-24. Am J Hum Genet. 34:227–234.
1982.PubMed/NCBI
|
|
15
|
Handwerger S and Freemark M: The roles of
placental growth hormone and placental lactogen in the regulation
of human fetal growth and development. J Pediatr Endocrinol Metab.
13:343–356. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Freemark M, Fleenor D, Driscoll P, Binart
N and Kelly P: Body weight and fat deposition in prolactin
receptor-deficient mice. Endocrinology. 142:532–537. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
George DL, Phillips JA III, Francke U and
Seeburg PH: The genes for growth hormone and chorionic
somatomammotropin are on the long arm of human chromosome 17 in
region q21 to qter. Hum Genet. 57:138–141. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Struman I, Bentzien F, Lee H, Mainfroid V,
D'Angelo G, Goffin V, Weiner RI and Martial JA: Opposing actions of
intact and N-terminal fragments of the human prolactin/growth
hormone family members on angiogenesis: An efficient mechanism for
the regulation of angiogenesis. Proc Natl Acad Sci USA.
96:1246–1251. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nachtigal MW, Nickel BE and Cattini PA:
Pituitary-specific repression of placental members of the human
growth hormone gene family. A possible mechanism for locus
regulation. J Biol Chem. 268:8473–8479. 1993.PubMed/NCBI
|
|
20
|
Lacroix MC, Guibourdenche J, Frendo JL,
Muller F and Evain-Brion D: Human placental growth hormone - a
review. Placenta. 23 Suppl A:S87–S94. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Silva CM, Kloth MT, Lyons CE, Dunn CR and
Kirk SE: Intracellular signaling by growth hormone variant (GH-V).
Growth Horm IGF Res. 12:374–380. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cacciari E, Pirazzoli P, Gualandi S,
Baroncini C, Baldazzi L, Trevisani B, Capelli M, Zucchini S,
Balsamo A, Cicognani A, et al: Molecular study of human growth
hormone gene cluster in three families with isolated growth hormone
deficiency and similar phenotype. Eur J Pediatr. 153:635–641. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mullis PE, Akinci A, Kanaka C, Eblé A and
Brook CG: Prevalence of human growth hormone-1 gene deletions among
patients with isolated growth hormone deficiency from different
populations. Pediatr Res. 31:532–534. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Frankenne F, Closset J, Gomez F, Scippo
ML, Smal J and Hennen G: The physiology of growth hormones (GHs) in
pregnant women and partial characterization of the placental GH
variant. J Clin Endocrinol Metab. 66:1171–1180. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Frankenne F, Scippo ML, van Beeumen J,
Igout A and Hennen G: Identification of placental human growth
hormone as the growth hormone-V gene expression product. J Clin
Endocrinol Metab. 71:15–18. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nickel BE, Kardami E and Cattini PA: The
human placental growth hormone variant is mitogenic for rat
lymphoma Nb2 cells. Endocrinology. 126:971–976. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cooke NE, Ray J, Emery JG and Liebhaber
SA: Two distinct species of human growth hormone-variant mRNA in
the human placenta predict the expression of novel growth hormone
proteins. J Biol Chem. 263:9001–9006. 1988.PubMed/NCBI
|
|
28
|
Selden RF, Wagner TE, Blethen S, Yun JS,
Rowe ME and Goodman HM: Expression of the human growth hormone
variant gene in cultured fibroblasts and transgenic mice. Proc Natl
Acad Sci USA. 85:8241–8245. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ghizzoni L, Duquesnoy P, Torresani T,
Vottero A, Goossens M and Bernasconi S: Isolated growth hormone
deficiency type IA associated with a 45-kilobase gene deletion
within the human growth hormone gene cluster in an Italian family.
Pediatr Res. 36:654–659. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mirlesse V, Frankenne F, Alsat E, Poncelet
M, Hennen G and Evain-Brion D: Placental growth hormone levels in
normal pregnancy and in pregnancies with intrauterine growth
retardation. Pediatr Res. 34:439–442. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Moghadam S, Engel W, Bougoussa M, Hennen
G, Igout A and Sancken U: Maternal serum placental growth hormone
and insulinlike growth factor binding proteins 1 and 3 in
pregnancies affected by fetal aneuploidy and other abnormalities:
Implications for prenatal diagnosis of trisomy 21. Fetal Diagn
Ther. 13:291–297. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Curran AJ, Peacey SR and Shalet SM: Is
maternal growth hormone essential for a normal pregnancy? Eur J
Endocrinol. 139:54–58. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Papadopoulou E, Sifakis S, Giahnakis E,
Fragouli Y, Karkavitsas N, Koumantakis E and Kalmanti M: Human
placental growth hormone is increased in maternal serum in
pregnancies affected by Down syndrome. Fetal Diagn Ther.
23:211–216. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Freemark M: Regulation of maternal
metabolism by pituitary and placental hormones: Roles in fetal
development and metabolic programming. Horm Res. 65 Suppl 3:41–49.
2006.PubMed/NCBI
|
|
35
|
Ray J, Okamura H, Kelly PA, Cooke NE and
Liebhaber SA: Human growth hormone-variant demonstrates a receptor
binding profile distinct from that of normal pituitary growth
hormone. J Biol Chem. 265:7939–7944. 1990.PubMed/NCBI
|
|
36
|
Gootwine E: Placental hormones and
fetal-placental development. Anim Reprod Sci 82–83. 1–566.
2004.
|
|
37
|
Schock H, Zeleniuch-Jacquotte A, Lundin E,
Grankvist K, Lakso HÅ, Idahl A, Lehtinen M, Surcel HM and Fortner
RT: Hormone concentrations throughout uncomplicated pregnancies: A
longitudinal study. BMC Pregnancy Childbirth. 16:1462016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Walker WH, Fitzpatrick SL, Barrera-Saldaña
HA, Resendez-Perez D and Saunders GF: The human placental lactogen
genes: Structure, function, evolution and transcriptional
regulation. Endocr Rev. 12:316–328. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Freemark M: Placental hormones and the
control of fetal growth. J Clin Endocrinol Metab. 95:2054–2057.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
MacLeod JN, Worsley I, Ray J, Friesen HG,
Liebhaber SA and Cooke NE: Human growth hormone-variant is a
biologically active somatogen and lactogen. Endocrinology.
128:1298–1302. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wu Z, Bidlingmaier M, Friess SC, Kirk SE,
Buchinger P, Schiessl B and Strasburger CJ: A new nonisotopic,
highly sensitive assay for the measurement of human placental
growth hormone: Development and clinical implications. J Clin
Endocrinol Metab. 88:804–811. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Männik J, Vaas P, Rull K, Teesalu P,
Rebane T and Laan M: Differential expression profile of growth
hormone/chorionic somatomammotropin genes in placenta of small- and
large-for-gestational-age newborns. J Clin Endocrinol Metab.
95:2433–2442. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ursell W, Brudenell M and Chard T:
Placental lactogen levels in diabetic pregnancy. BMJ. 2:80–82.
1973. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Langford KS, Nicolaides KH, Jones J, Abbas
A, McGregor AM and Miell JP: Serum insulin-like growth
factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease
activity in normal, abnormal, and multiple human pregnancy. J Clin
Endocrinol Metab. 80:21–27. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Reece EA, Wiznitzer A, Le E, Homko CJ,
Behrman H and Spencer EM: The relation between human fetal growth
and fetal blood levels of insulin-like growth factors I and II,
their binding proteins, and receptors. Obstet Gynecol. 84:88–95.
1994.PubMed/NCBI
|
|
46
|
Coutant R, de Casson F Boux, Douay O,
Mathieu E, Rouleau S, Beringue F, Gillard P, Limal JM and Descamps
P: Relationships between placental GH concentration and maternal
smoking, newborn gender, and maternal leptin: Possible implications
for birth weight. J Clin Endocrinol Metab. 86:4854–4859. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Boutsikou T, Malamitsi-Puchner A, Economou
E, Boutsikou M, Puchner KP and Hassiakos D: Soluble vascular
endothelial growth factor receptor-1 in intrauterine growth
restricted fetuses and neonates. Early Hum Dev. 82:235–239. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Malamitsi-Puchner A, Boutsikou T, Economou
E, Sarandakou A, Makrakis E, Hassiakos D, et al: Vascular
endothelial growth factor and placenta growth factor in
intrauterine growth-restricted fetuses and neonates. Mediat
Inflamm. 2005:293–297. 2005. View Article : Google Scholar
|
|
49
|
Kedzia A, Tarka A, Petriczko E, Pruski D
and Iwaniec K: Placental growth hormone (PGH), pituitary growth
hormone (GH1), insulin-like growth factor (IGF-I) and ghrelin in
pregnant women's blood serum. Ginekol Pol. 84:620–623. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Pedersen NG, Juul A, Christiansen M,
Wøjdemann KR and Tabor A: Maternal serum placental growth hormone,
but not human placental lactogen or insulin growth factor-1, is
positively associated with fetal growth in the first half of
pregnancy. Ultrasound Obstet Gynecol. 36:534–541. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chellakooty M, Skibsted L, Skouby SO,
Andersson AM, Petersen JH, Main KM, Skakkebaek NE and Juul A:
Longitudinal study of serum placental GH in 455 normal pregnancies:
Correlation to gestational age, fetal gender, and weight. J Clin
Endocrinol Metab. 87:2734–2739. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Eriksson L, Frankenne F, Edèn S, Hennen G
and Von Schoultz B: Growth hormone 24-h serum profiles during
pregnancy-lack of pulsatility for the secretion of the placental
variant. Br J Obstet Gynaecol. 96:949–953. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Liebhaber SA, Urbanek M, Ray J, Tuan RS
and Cooke NE: Characterization and histologic localization of human
growth hormone-variant gene expression in the placenta. J Clin
Invest. 83:1985–1991. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Scippo ML, Frankenne F, Hooghe-Peters EL,
Igout A, Velkeniers B and Hennen G: Syncytiotrophoblastic
localization of the human growth hormone variant mRNA in the
placenta. Mol Cell Endocrinol. 92:R7–R13. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Mittal P, Espinoza J, Hassan S, Kusanovic
JP, Edwin SS, Nien JK, Gotsch F, Than NG, Erez O, Mazaki-Tovi S, et
al: Placental growth hormone is increased in the maternal and fetal
serum of patients with preeclampsia. J Matern Fetal Neonatal Med.
20:651–659. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Goodman HM, Tai LR, Ray J, Cooke NE and
Liebhaber SA: Human growth hormone variant produces insulin-like
and lipolytic responses in rat adipose tissue. Endocrinology.
129:1779–1783. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Street ME, Seghini P, Fieni S, Ziveri MA,
Volta C, Martorana D, Viani I, Gramellini D and Bernasconi S:
Changes in interleukin-6 and IGF system and their relationships in
placenta and cord blood in newborns with fetal growth restriction
compared with controls. Eur J Endocrinol. 155:567–574. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Street ME, Seghini P, Ziveri MA, Fieni S,
Volta C, Neri TM, Viani I, Bacchi-Modena A and Bernasconi S:
Interleukin-6 and insulin-like growth factor system relationships
and differences in the human placenta and fetus from the 35th week
of gestation. Growth Horm IGF Res. 16:365–372. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Fowden AL and Forhead AJ: Endocrine
regulation of feto-placental growth. Horm Res. 72:257–265. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Handwerger S: The growth hormone gene
cluster: Physiological actions and regulation during pregnancy.
Growth Genet Horm. 25:1–8. 2009.
|
|
61
|
Rechler MM and Clemmons DR: Regulatory
Actions of Insulin-like Growth Factor-binding Proteins. Trends
Endocrinol Metab. 9:176–183. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Freemark M, Avril I, Fleenor D, Driscoll
P, Petro A, Opara E, Kendall W, Oden J, Bridges S, Binart N, et al:
Targeted deletion of the PRL receptor: Effects on islet
development, insulin production, and glucose tolerance.
Endocrinology. 143:1378–1385. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Fleenor D, Oden J, Kelly PA, Mohan S,
Alliouachene S, Pende M, Wentz S, Kerr J and Freemark M: Roles of
the lactogens and somatogens in perinatal and postnatal metabolism
and growth: Studies of a novel mouse model combining lactogen
resistance and growth hormone deficiency. Endocrinology.
146:103–112. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
McDonald EA and Wolfe MW: Adiponectin
attenuation of endocrine function within human term trophoblast
cells. Endocrinology. 150:4358–4365. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Arumugam R, Fleenor D and Freemark M:
Effects of lactogen resistance and GH deficiency on mouse
metabolism: Pancreatic hormones, adipocytokines, and expression of
adiponectin and insulin receptors. Endocrine. 32:182–191. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wallner W, Sengenberger R, Strick R,
Strissel PL, Meurer B, Beckmann MW and Schlembach D: Angiogenic
growth factors in maternal and fetal serum in pregnancies
complicated by intrauterine growth restriction. Clin Sci (Lond).
112:51–57. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Christiansen M: Placental growth hormone
and growth hormone binding protein are first trimester maternal
serum markers of Down syndrome. Prenat Diagn. 29:1249–1255. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Fisker S, Ebdrup L and Orskov H: Influence
of growth hormone binding protein on growth hormone estimation in
different immunoassays. Scand J Clin Lab Invest. 58:373–381. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Baviera G, Carbone C, Corrado F and
Mastrantonio P: Placental growth hormone in Down's syndrome
screening. J Matern Fetal Neonatal Med. 16:241–243. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Leung TY, Chan LW, Leung TN, Fung TY,
Sahota DS and Lau TK: First-trimester maternal serum levels of
placental hormones are independent predictors of second-trimester
fetal growth parameters. Ultrasound Obstet Gynecol. 27:156–161.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Sifakis S, Papadopoulou E, Konstantinidou
A, Giahnakis E, Fragouli Y, Karkavitsas N, Koumantakis E and
Kalmanti M: Increased levels of human placental growth hormone in
the amniotic fluid of pregnancies affected by Down syndrome. Growth
Horm IGF Res. 19:121–125. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Sifakis S, Akolekar R, Syngelaki A, De
Cruz J and Nicolaides KH: Maternal serum human placental growth
hormone at 11 to 13 weeks in trisomy 21 and trisomy 18 pregnancies.
Prenat Diagn. 30:212–215. 2010.PubMed/NCBI
|
|
73
|
Alldred SK, Takwoingi Y, Guo B, Pennant M,
Deeks JJ, Neilson JP and Alfirevic Z: First trimester serum tests
for Down's syndrome screening. Cochrane Database Syst Rev.
11:CD0119752015.
|
|
74
|
Verhaeghe J: Does the physiological
acromegaly of pregnancy benefit the fetus? Gynecol Obstet Invest.
66:217–226. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Chaiworapongsa T, Romero R, Espinoza J,
Bujold E, Mee Kim Y, Gonçalves LF, Gomez R and Edwin S: Evidence
supporting a role for blockade of the vascular endothelial growth
factor system in the pathophysiology of preeclampsia. Young
Investigator Award. Am J Obstet Gynecol. 190:1541–1547, discussion
1547–1550. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Koga K, Osuga Y, Yoshino O, Hirota Y,
Ruimeng X, Hirata T, Takeda S, Yano T, Tsutsumi O and Taketani Y:
Elevated serum soluble vascular endothelial growth factor receptor
1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol
Metab. 88:2348–2351. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Maynard SE, Min JY, Merchan J, Lim KH, Li
J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, et
al: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may
contribute to endothelial dysfunction, hypertension, and
proteinuria in preeclampsia. J Clin Invest. 111:649–658. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
McKeeman GC, Ardill JE, Caldwell CM,
Hunter AJ and McClure N: Soluble vascular endothelial growth factor
receptor-1 (sFlt-1) is increased throughout gestation in patients
who have preeclampsia develop. Am J Obstet Gynecol. 191:1240–1246.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Evain-Brion D: Hormonal regulation of
fetal growth. Horm Res. 42:207–214. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Papadopoulou E, Sifakis S, Giahnakis E,
Fragouli Y, Karkavitsas N, Koumantakis E and Kalmanti M: Increased
human placental growth hormone at midtrimester pregnancies may be
an index of intrauterine growth retardation related to
preeclampsia. Growth Horm IGF Res. 16:290–296. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Chaiworapongsa T, Romero R, Kim YM, Kim
GJ, Kim MR, Espinoza J, Bujold E, Gonçalves L, Gomez R, Edwin S, et
al: Plasma soluble vascular endothelial growth factor receptor-1
concentration is elevated prior to the clinical diagnosis of
pre-eclampsia. J Matern Fetal Neonatal Med. 17:3–18. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Crispi F, Domínguez C, Llurba E,
Martín-Gallán P, Cabero L and Gratacós E: Placental angiogenic
growth factors and uterine artery Doppler findings for
characterization of different subsets in preeclampsia and in
isolated intrauterine growth restriction. Am J Obstet Gynecol.
195:201–207. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Rajakumar A, Michael HM, Rajakumar PA,
Shibata E, Hubel CA, Karumanchi SA, Thadhani R, Wolf M, Harger G
and Markovic N: Extra-placental expression of vascular endothelial
growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by
peripheral blood mononuclear cells (PBMCs) in normotensive and
preeclamptic pregnant women. Placenta. 26:563–573. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Evain-Brion D, Alsat E, Igout A, Frankenne
F and Hennen G: Placental growth hormone variant: Assay and
clinical aspects. Acta Paediatr Suppl. 399(s399): 49–51; discussion
52. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Kupferminc MJ, Daniel Y, Englender T,
Baram A, Many A, Jaffa AJ, Gull I and Lessing JB: Vascular
endothelial growth factor is increased in patients with
preeclampsia. Am J Reprod Immunol. 38:302–306. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Krauss T, Pauer HU and Augustin HG:
Prospective analysis of placenta growth factor (PlGF)
concentrations in the plasma of women with normal pregnancy and
pregnancies complicated by preeclampsia. Hypertens Pregnancy.
23:101–111. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Levine RJ and Karumanchi SA: Circulating
angiogenic factors in preeclampsia. Clin Obstet Gynecol.
48:372–386. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Levine RJ, Lam C, Qian C, Yu KF, Maynard
SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, et al:
CPEP Study Group: Soluble endoglin and other circulating
antiangiogenic factors in preeclampsia. N Engl J Med. 355:992–1005.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Levine RJ, Maynard SE, Qian C, Lim KH,
England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein
FH, et al: Circulating angiogenic factors and the risk of
preeclampsia. N Engl J Med. 350:672–683. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Levine RJ, Thadhani R, Qian C, Lam C, Lim
KH, Yu KF, Blink AL, Sachs BP, Epstein FH, Sibai BM, et al: Urinary
placental growth factor and risk of preeclampsia. JAMA. 293:77–85.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Lyall F, Greer IA, Boswell F and Fleming
R: Suppression of serum vascular endothelial growth factor
immunoreactivity in normal pregnancy and in pre-eclampsia. Br J
Obstet Gynaecol. 104:223–228. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Robinson CJ, Johnson DD, Chang EY,
Armstrong DM and Wang W: Evaluation of placenta growth factor and
soluble Fms-like tyrosine kinase 1 receptor levels in mild and
severe preeclampsia. Am J Obstet Gynecol. 195:255–259. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Staff AC, Braekke K, Harsem NK, Lyberg T
and Holthe MR: Circulating concentrations of sFlt1 (soluble
fms-like tyrosine kinase 1) in fetal and maternal serum during
pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 122:33–39. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Thadhani R, Mutter WP, Wolf M, Levine RJ,
Taylor RN, Sukhatme VP, Ecker J and Karumanchi SA: First trimester
placental growth factor and soluble fms-like tyrosine kinase 1 and
risk for preeclampsia. J Clin Endocrinol Metab. 89:770–775. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Torry DS, Wang HS, Wang TH, Caudle MR and
Torry RJ: Preeclampsia is associated with reduced serum levels of
placenta growth factor. Am J Obstet Gynecol. 179:1539–1544. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Venkatesha S, Toporsian M, Lam C, Hanai J,
Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, et al:
Soluble endoglin contributes to the pathogenesis of preeclampsia.
Nat Med. 12:642–649. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Zhou Y, McMaster M, Woo K, Janatpour M,
Perry J, Karpanen T, Alitalo K, Damsky C and Fisher SJ: Vascular
endothelial growth factor ligands and receptors that regulate human
cytotrophoblast survival are dysregulated in severe preeclampsia
and hemolysis, elevated liver enzymes, and low platelets syndrome.
Am J Pathol. 60:1405–1423. 2002. View Article : Google Scholar
|
|
98
|
Koutsaki M, Sifakis S, Zaravinos A,
Koutroulakis D, Koukoura O and Spandidos DA: Decreased placental
expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by
fetal growth restriction. Growth Horm IGF Res. 21:31–36. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Sifakis S, Akolekar R, Kappou D, Mantas N
and Nicolaides KH: Maternal serum placental growth hormone at 11–13
weeks' gestation in pregnancies delivering small for gestational
age neonates. J Matern Fetal Neonatal Med. 25:1796–1799. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Hu L, Lytras A, Bock ME, Yuen CK, Dodd JG
and Cattini PA: Detection of placental growth hormone variant and
chorionic somatomammotropin-L RNA expression in normal and diabetic
pregnancy by reverse transcriptase-polymerase chain reaction. Mol
Cell Endocrinol. 157:131–142. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Eleftheriades M, Papastefanou I,
Lambrinoudaki I, Kappou D, Lavranos D, Akalestos A, Souka AP,
Pervanidou P, Hassiakos D and Chrousos GP: Elevated placental
growth factor concentrations at 11–14 weeks of gestation to predict
gestational diabetes mellitus. Metabolism. 63:1419–1425. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Higgins MF, Russell NE, Crossey PA, Nyhan
KC, Brazil DP and McAuliffe FM: Maternal and fetal placental growth
hormone and IGF axis in type 1 diabetic pregnancy. PLoS One.
7:e291642012. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Fuglsang J, Lauszus F, Flyvbjerg A and
Ovesen P: Human placental growth hormone, insulin-like growth
factor I and -II, and insulin requirements during pregnancy in type
1 diabetes. J Clin Endocrinol Metab. 88:4355–4361. 2003. View Article : Google Scholar
|
|
104
|
Ringholm L, Juul A, Pedersen-Bjergaard U,
Thorsteinsson B, Damm P and Mathiesen ER: Lower levels of placental
growth hormone in early pregnancy in women with type 1 diabetes and
large for gestational age infants. Growth Horm IGF Res. 25:312–315.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
McIntyre HD, Zeck W and Russell A:
Placental growth hormone, fetal growth and the IGF axis in normal
and diabetic pregnancy. Curr Diabetes Rev. 5:185–189. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Schock H, Fortner RT, Surcel HM, Grankvist
K, Pukkala E, Lehtinen M and Lundin E: Early pregnancy IGF-I and
placental GH and risk of epithelial ovarian cancer: A nested
case-control study. Int J Cancer. 137:439–447. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Hübener C, Bidlingmaier M, Wu Z, Diebold
J, Delius M, Friese K, Strasburger CJ and Hasbargen U: Human
placental growth hormone: A potential new biomarker in gestational
trophoblastic disease. Gynecol Oncol. 136:264–268. 2015. View Article : Google Scholar : PubMed/NCBI
|
